Epigenetic Regulation By PKC-theta In Human Breast Cancer Stem Cells.
Funder
National Health and Medical Research Council
Funding Amount
$818,132.00
Summary
Treating women with advanced breast cancer is difficult, and new drugs are needed to kill the cancer stem cells that cause recurrence. We think that a newly discovered protein, PKC-?, plays an important role in recurring breast cancer and can be targeted using novel ‘epigenetic’ drugs. Here, we will use cutting-edge DNA techniques to learn how this protein controls how cancer cells grow and produce the necessary data to show that targeting this protein is likely to be effective in real patients.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE110100161
Funder
Australian Research Council
Funding Amount
$366,384.00
Summary
The Victorian integrated plasmonics facility. This integrated plasmonics facility will create a centre for the design and application of metal nanostructures in a range of applications by biologists, chemists, physicists and engineers.